External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

ATS 2024

-
06:30 PM
Duration 2hrs San Diego, USA
Safety Profile of Astegolimab, An Anti-ST2 Antibody: A Systematic Review
Kelsen S, Alvaro G, Millette L, Mohan D, Yang X, Brightling CE
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
09:15 PM
Duration 2hrs San Diego, USA
Zinpentraxin Alfa in Patients With Idiopathic Pulmonary Fibrosis (IPF): Results and Learnings From the Phase III STARSCAPE Trial
Richeldi L, Schiffman C, Behr J, Inoue Y, Corte TJ, Cottin V, Jenkins G, Nathan SD, Raghu G, Walsh SLF, Jayia P, Kamath N, Martinez FJ
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 1hr United States
Zinpentraxin Alfa in Patients With Idiopathic Pulmonary Fibrosis: Results and Learnings From the Phase III STARSCAPE Trial
Richeldi L, Schiffman C, Behr J, Inoue Y, Corte TJ, Cottin V, Jenkins G, Nathan SD, Raghu G, Walsh SLF, Jayia P, Kamath N, Martinez FJ
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Coming soon